News
Eli Lilly and Gilead's combination cuts COVID-19 recovery ti...
Eli Lilly’s Olumiant (baricitinib) has a significant effect on recovery from COVID-19 when combined with Gilead Veklury (remdesivir), according to a large trial backed by funding from the U
